NICE has recommended teduglutide (Revestive) in final draft guidance for people with short bowel syndrome who are aged 1 year and above and are in a stable condition following surgery to remove an abnormal bowel.
According to NICE final draft guidance, fenfluramine, when added to standard care medicines, reduces the number of convulsive seizures people have. It may also be more effective than cannabidiol plus clobazam in reducing the number of seizures when used with 2 other antiepileptic medicines.
You can consent to the use of such technologies by closing this notice.
Customise your preferences for any tracking technology
The following allows you to customize your consent preferences for any tracking technology used
to help us achieve the features and activities described below. To learn more about how these trackers help us